A clinical trial supported by the National Institutes of Health (NIH) is testing an experimental treatment designed to help people suffering the effects of dengue, a mosquito-borne viral disease.

A recent study published in Nature Communications by researchers at the National Institute of Allergy and Infectious Diseases (NIAID) and collaborators evaluated a replicating RNA (repRNA) vaccine ...

Biopharmaceutical company Ocugen, Inc. (NASDAQ: OCGN) has announced that the U.S. Food and Drug Administration (FDA) has ...

C olorized transmission electron micrograph of mpox virus particles (green) cultivated and purified from cell culture. Image ...

These and other major medical breakthroughs exist in large part thanks to a major division of the National Institutes of Health, the largest funder of biomedical research on the planet.

President Trump has sparked fresh controversy in his first week back in office with his decision to remove security details ...

Oklahoma’s top prosecutor is asking the federal Bureau of Prisons to transfer an inmate to state custody so that he can be ...

On his way out of the White House on Jan. 20, Joe Biden issued a preemptive pardon for, among others, his chief medical advisor, Dr. Anthony Fauci. The week before, the federal Department of Health ...

Former federal prosecutor Jim Trusty said Tuesday that former President Joe Biden’s preemptive pardon of former National ...

One strategy antiabortion advocates may increasingly rely upon as they attempt to block medication abortion from reaching ...

With its $6.5 billion budget, NIAID has played a vital role in discoveries that have kept the nation at the forefront of infectious disease research and saved millions of lives. Then came the COVID-19 ...